Tatsuya Suzuki

Updated Trends in Cancer in Japan: Incidence in 1985–2015 and Mortality in 1958–2018—A Sign of Decrease in Cancer Incidence

Kota Katanoda, Megumi Hori, Eiko Saito et al. · Journal of Epidemiology · 2021 · 148 citations · Full text

A multicentre phase <scp>II</scp> study of vorinostat in patients with relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

Michinori Ogura, Kiyoshi Ando, Tatsuya Suzuki et al. · British Journal of Haematology · 2014 · 110 citations · Full text

Phase I study of inotuzumab ozogamicin (CMC‐544) in Japanese patients with follicular lymphoma pretreated with rituximab‐based therapy

Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake et al. · Cancer Science · 2010 · 56 citations · Full text

Inotuzumab Ozogamicin, Lymphoid Neoplasia, Hematological Malignancy +14

Phase I / II study of brentuximab vedotin in <scp>J</scp>apanese patients with relapsed or refractory <scp>CD</scp>30‐positive <scp>H</scp>odgkin's lymphoma or systemic anaplastic large‐cell lymphoma

Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake et al. · Cancer Science · 2014 · 54 citations · Full text

Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan

Jun Kido, Shirou Matsumoto, Johannes Häberle et al. · Journal of Inherited Metabolic Disease · 2021 · 35 citations